Advertisement

Topics

Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People ...

08:06 EDT 12 Jul 2018 | BioMedReports - Blog

– Venclexta represents a potential new way of treating AML, the most common type of aggressive leukemia in adults –

Read more...

Original Article: Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People ...

NEXT ARTICLE

More From BioPortfolio on "Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...